Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "COPE"

203 News Found

Venus Remedies expands reach with the launch of Elores in Ecuador
News | October 14, 2023

Venus Remedies expands reach with the launch of Elores in Ecuador

The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries


Lupin acquires five brands from Menarini
News | September 23, 2023

Lupin acquires five brands from Menarini

Lupin has been exclusively marketing these brands in the Indian market since July 2021


JB Pharma publishes sustainability report for FY 2022-23
Sustainability | September 12, 2023

JB Pharma publishes sustainability report for FY 2022-23

JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions


SÜDPACK Medica presents PharmaGuard at CPHI in Barcelona
News | September 11, 2023

SÜDPACK Medica presents PharmaGuard at CPHI in Barcelona

SÜDPACK customers also benefit when it comes to processing PharmaGuard


Sodexo launches patient nutrition solution 'Aarogyum’
News | September 08, 2023

Sodexo launches patient nutrition solution 'Aarogyum’

With All India Institute of Ayurveda as a knowledge partner and Sodexo’s culinary expertise, Aarogyum is a well-rounded offering in patient dining solutions


Mankind Pharma launches 120 premium DMF quality drugs for Indian Patients
News | August 30, 2023

Mankind Pharma launches 120 premium DMF quality drugs for Indian Patients

Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre


BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
Diagnostic Center | August 29, 2023

BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint

Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year


Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
Diagnostic Center | August 28, 2023

Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders

In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers


India’s MRI systems market to reach $950 million by 2030, forecasts GlobalData
News | August 25, 2023

India’s MRI systems market to reach $950 million by 2030, forecasts GlobalData

India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023


Altana acquires ultrasound metrology company Imaginant
News | August 09, 2023

Altana acquires ultrasound metrology company Imaginant

Imaginant offers a unique measurement capability through its PELT coating thickness gauges